Counselors in North Liberty, IA Accepting Medicare

25 Counselors found. Showing 21 - 25

Taylor Elizabeth Bagley, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 575 Cameron Way Ste A, North Liberty, IA 52317 Phone: 319-626-2558

Emily Rae Michener, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 320 W Cherry St, North Liberty, IA 52317 Phone: 319-626-3300

Christine Skow, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 595 Ashley Ct, Suite 1, North Liberty, IA 52317 Phone: 319-665-2525    Fax: 319-665-2519

Ms. Penny Jaymes Clark, L.M.H.C. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1290 Jordan St, North Liberty, IA 52317 Phone: 319-356-6352    Fax: 319-358-2367

Tayler Foster Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1290 Jordan St, North Liberty, IA 52317 Phone: 319-356-6352    Fax: 319-356-6352

News Archive

Proposed rules to revise family and medical leave act prompt debate over law

The Bush administration appears "intent on putting its stamp" on the Family and Medical Leave Act through rules that would increase restrictions, but the proposals face "fierce" opposition, the Washington Post reports.

Tips to ease daylight saving time transition

Daylight saving time begins at 2 a.m. on Sunday, March 9, bringing more sunshine in the evenings at the price of an hour of sleep. Vanderbilt Sleep Disorders Center specialist Kelly Brown, M.D., says a little extra planning can alleviate that groggy feeling that often accompanies the time change.

Drinking milk during breastfeeding can reduce food allergy in children

Children of mothers who drink relatively more cow's milk during breastfeeding are at reduced risk of developing food allergies. That is the conclusion of researchers from Chalmers University of Technology, Sweden, in a new study published in the scientific journal Nutrients.

Preclinical data of ZIO-101 in various lymphoma models presented at ASH 2010

ZIOPHARM Oncology, Inc. announced today that new preclinical data on the novel mechanism of its organic arsenic darinaparsin (ZIO-101) in various lymphoma models were presented at the 52nd Annual Meeting and Exposition of the American Society of Hematology in Orlando Florida.

Nymox near completion of new NX-1207 follow-up study for BPH

Nymox Pharmaceutical Corporation announced today that the Company is nearing completion of a new multi-center U.S. long-term follow-up study of NX-1207, its investigational drug for the treatment of benign prostatic hyperplasia (BPH). Nymox expects to report final results and statistical analysis for the study in the next 1-2 weeks. The new study concerns assessment of the 48-60 month efficacy and benefits of a single treatment of NX-1207.

Read more Medical News

› Verified 6 days ago

• 1
• 2(current)